The restriction endonuclease PvuII from Proteus vulgaris has been converted from its wild-type homodimeric form into the enzymatically active single-chain variant scPvuII by tandemly joining the two subunits through the peptide linker Gly-Ser-Gly-Gly. scPvuII, which is suitable for the development of programmed restriction endonucleases for highly specific DNA cleavage, was purified and crystallized. The crystals diffract to a resolution of 2.35 Å and belong to space group P4 2 , with unit-cell parameters a = b = 101.92, c = 100.28 Å and two molecules per asymmetric unit. Phasing was successfully performed by molecular replacement.
Introduction
The PvuII restriction endonuclease is the nuclease component of one of the Proteus vulgaris type II restriction-modification systems (Blumenthal et al., 1985; Gingeras et al., 1981) . Like most type II endonucleases (Niv et al., 2007; Pingoud & Jeltsch, 1997; Kovall & Matthews, 1999; Roberts & Halford, 1993; Roberts & Macelis, 2000) , PvuII is homodimeric and cleaves its double-stranded cognate DNA substrate in the presence of Mg 2+ so that each subunit acts on one DNA strand in a concerted manner. The enzyme cleaves the palindromic 5 0 -CAGCTG-3 0 sequence between the central GC residues and generates blunt ends with a 5 0 -phosphate group. With 157 aminoacid residues, PvuII is one of the smallest type II restriction endonucleases (Athanasiadis et al., 1990; Tao & Blumenthal, 1992) . The crystal structure of the protein (Athanasiadis et al., 1994; Cheng et al., 1994) showed that the C-terminus of one subunit is in close proximity to the N-terminus of the other. This particular feature of the PvuII restriction endonuclease raised the interesting possibility of engineering a single-chain (sc) enzyme by linking these termini with a short peptide linker. Simoncsits et al. (2001) converted PvuII from its natural homodimeric form into a single polypeptide chain (scPvuII) by tandemly linking the two subunits of the wild-type enzyme (wt) through the peptide linker Gly-Ser-Gly-Gly. The protein (including the C-terminal histidine tag Gly-Ser-His 6 ) has a molecular weight of 36 912.3 Da and comprises 326 residues.
The results of in vivo and in vitro tests (Simoncsits et al., 2001) showed that the cleavage specificity of scPvuII is indistinguishable from that of the wt enzyme; the engineered protein is a potent catalyst, although somewhat less efficient than wt PvuII. Such a functional single-chain restriction endonuclease could prove to be an invaluable tool in protein-engineering studies, both in basic research and in practical applications. scPvuII has found applications in ongoing studies to develop programmed restriction endonucleases for highly specific DNA cleavage suitable for the analysis of genomic DNA or for targeting individual genes in complex genomes: scPvuII covalently coupled via a bifunctional cross-linker to a triple-helixforming oligonucleotide (TFO) specifically cleaves high-molecularweight DNA at PvuII recognition sites if these are located at a distance of approximately one helical turn from a triple-helix-forming site (TFS) which is complementary to the TFO (Eisenschmidt et al., 2005) ; other PvuII sites are left intact. Given the fact that TFO can be synthesized to form triple helices with any sequence that one would like to address (Rusling et al., 2005) and that triple-helix formation can be used to target genes in vivo (Majumdar et al., 2003) , the scPvuII variant can be considered as a programmable restriction enzyme that offers a useful alternative to designed zinc-finger nucleases in highly efficient endogenous gene-correction applications Kandavelou et al., 2005; Urnov et al., 2005) .
Materials and methods

Expression and purification
The scpvuII gene was cloned in the expression vector pRIZ 0 -scPvR-GSH6 (Simoncsits et al., 2001 ) containing a C-terminal His tag and transformed into XL1 BlueMRF 0 hosts (Escherichia coli strains) which contain the pLGM PvuII methylase construct. A sufficient amount of soluble protein for structural studies was obtained after expression using the following conditions. Cells were grown in 1 l LB medium containing 100 mg ml À1 ampicillin, 25 mg ml À1 kanamycin and 5 mg ml À1 tetracycline at 310 K until an OD 600 of 0.9 was reached. The culture was induced with 0.5 mM isopropyl -d-1-thiogalactopyranoside (IPTG) for 4-6 h at 310 K and harvested by centrifugation at 6000 rev min À1 for 30 min at 277 K. The pelleted cells were resuspended in 50 ml lysis buffer containing 50 mM Na 2 HPO 4 / NaH 2 PO 4 pH 8, 300 mM NaCl, 5 mM imidazole with 5 mM 2-mercaptoethanol. Subsequently, 1 mM PMSF, 20 mg ml À1 leupeptin and 150 mg ml À1 benzamidine were added and homogenized by sonication at 277 K. The cell debris was removed by centrifugation at 14 000 rev min À1 for 1 h at 277 K. Purification was effected via the His tag by affinity chromatography at 277 K on a 5 ml Ni-NTA agarose column (Qiagen) pre-equilibrated in lysis buffer. The column was washed with ten column volumes of lysis buffer containing 10 mM imidazole and ten column volumes of lysis buffer containing 20 mM imidazole, followed by a gradient from 50 to 300 mM imidazole in lysis buffer. scPvuII started to elute at 100 mM imidazole in lysis buffer. Fractions containing more than 95% homogeneous scPvuII, as visualized by SDS-PAGE gels, were dialyzed extensively against 20 mM Tris-HCl pH 7.5 buffer containing 20 mM NaCl. The protein solution was concentrated to 7 mg ml À1 using Amicon Centriprep (YM-10) filters and kept in 20 mM Tris-HCl pH 7.5 buffer for subsequent crystallization experiments. The protein concentration was determined using the Bradford assay with bovine serum albumin as a standard (Bradford, 1976) . A total of 14 mg pure protein was the final yield from 3 g cell paste.
Crystallization
Crystallization trials were performed using the hanging-drop vapour-diffusion method and Linbro 24-well cell-culture plates. The drops consisted of 3 ml protein (at 5-9 mg ml À1 ) plus 3 ml reservoir solution and were equilibrated against 1000 ml reservoir solution at 290 K. Well formed parallelepiped-shaped crystals of reasonable size for crystallographic studies were obtained within 3 d with 1.28-1.36 M ammonium sulfate, 4-5% MPD, 100 mM bis-Tris pH 6.5-7.4. The best results were reproducibly obtained using protein at a concentration of 7 mg ml À1 no later than 5 d after purification. The approximate dimensions of these crystals were 0.9 Â 0.3 Â 0.3 mm (Fig. 1) . Crystals of comparable quality were also obtained when fresh protein was flash-frozen in liquid nitrogen, stored at 190 K and defrosted on ice prior to crystallization.
Data collection, processing and phasing
X-ray diffraction data were collected from a single crystal (Fig. 1) to a resolution of 2.35 Å (Fig. 2) using synchrotron radiation at the EMBL X11 beamline at the DORIS storage ring, DESY, Hamburg (wavelength 1.84 Å ). The crystal was flash-cooled to 100 K in a nitrogen-gas cold stream using an Oxford Cryosystem device and a cryoprotection solution consisting of 1 M ammonium sulfate, 100 mM bis-Tris pH 7.2 and 25% glycerol. 360 images with an oscillation range of 0.5 were collected. The diffraction data were recorded on a MAR CCD165 detector with a diameter of 165 mm. X-ray diffraction data were indexed, integrated and scaled with DENZO and SCALE-PACK from the HKL program suite (Otwinowski & Minor, 1997) .
The scPvuII structure was solved by the molecular-replacement method using the program AMoRe (Navaza, 1994) . The DNA- The crystal of scPvuII used for the collection of X-ray diffraction data. The approximate length of the crystal is 0.9 mm. 
Results and discussion
scPvuII was successfully crystallized and a native data set was collected to 2.35 Å resolution using synchrotron radiation. The crystals belong to the tetragonal space group P4 2 , with unit-cell parameters a = b = 101.92, c = 100.28 Å . Data-collection and processing statistics are given in Table 1 . Scaling and merging of the crystallographic data resulted in an overall R merge of 7.5%. The completeness of the data set was 98.8% to 2.35 Å resolution. Assuming the presence of two molecules in the asymmetric unit, the Matthews coefficient (Matthews, 1968 ) is 3.6 Å 3 Da À1 and the solvent content is 65%. Both the space group (P4 2 ) and the content of the asymmetric unit (two molecules of scPvuII) were confirmed by structure solution using molecular replacement. Model rebuilding and structure refinement are in progress. 
